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Abstract
Background: The occurrence of tuberculosis (TB) among children has long been neglected as a public health concern.
However, any child with TB is a sentinel event indicating recent transmission. Vaccination, early case finding and
treatment of those latently infected with TB can prevent cases, severe morbidity and unnecessary death.
Method: The objective of the study was to describe the occurrence of TB events among children in the Netherlands
which may be avoided through preventive measures. For this purpose we performed a trend analysis of routine Dutch
TB and LTBI (surveillance data in 1993–2012 and a descriptive analysis of children with TB and with LTBI diagnosed in
2005–2012).
Results: Overall childhood TB incidence has declined over the last two decades from 3.6 in 1993 to 1.9 per 100,000
children in 2012. The decline was stronger among Dutch-born children compared to foreign-born children.
In 2005–2012 64% of childhood TB cases were detected through active case finding. Foreign-born children with
TB were less likely to be detected through active case finding, when not detected through post-entry TB screening.
Childhood TB diagnosis was culture confirmed in 68% of passively detected cases and 12% of actively detected cases.
Of 1,049 children with LTBI started on preventive treatment in 2005–2012, 90% completed treatment.
In 37% of all childhood TB cases there was at least one ‘missed opportunity’ for prevention. Thirty nine percent
of child TB patients eligible for BCG were not vaccinated.
Conclusion: Children with TB in the Netherlands are generally detected at an early stage and treatment completion
rates are high. However, more TB cases among children can be prevented through enhancing TB case finding and
screening and preventive treatment of latent TB infection among migrant children, and improving the coverage of
BCG vaccination among eligible risk groups.
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Background
According to estimates of the World Health Organization
530,000 tuberculosis (TB) cases occurred among children
in 2012, 6% of the total number of TB cases (WHO 2013).
In countries in the European Union and European Eco-
nomic Area, the percentage of children younger than
15 years of age among TB patients was 4.4% in 2011
(range 0–11.1%) [1]. Children with TB disease are gene-
rally not infectious, however TB infection and disease in a
child can be regarded as a sentinel event for ongoing
transmission. The clinical presentation of TB differs in
children from adults. Symptoms and signs are often non-
specific and vary from minor to life threatening. In chil-
dren TB typically presents by the formation of a primary
complex in the lungs consisting of a small peripheral
pulmonary focus and hilar or paratracheal lymph node in-
volvement. Bacteriological confirmation is difficult to ob-
tain [2-6]. International standards recommend sputum
induction, bronchoscopy or nasopharyngeal and gastric
lavage in children to obtain two to three samples for cul-
ture and drug sensitivity testing [7-10], but children often
have paucibacillary disease and samples often do not
contain detectable bacteria. Childhood TB control involves
diagnosis and treatment of TB disease with methods
appropriate for children, systematic active case-finding
among children in contact with infectious TB, therapy for
children with latent TB infection (LTBI) [11] to prevent
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progression to disease, and Bacillus Calmette-Guérin
(BCG) vaccination. BCG offers best protection if offered
at a young age [12].
In the Netherlands prevention and control of TB is the
responsibility of the Municipal Public Health Services
(MPHS). TB public health physicians in the MPHSs diag-
nose and treat two thirds of children with TB [13], while
one third of the children with TB is diagnosed and treated
by a large number of pediatricians and pulmonologists.
TB nurses of the MPHSs take care of daily observed
treatment (DOT) in children with TB or TB infection or
inform and instruct the parent or guardian how to ad-
minister the drugs. Prevention of TB in children focuses
on 1) active case finding through screening of new im-
migrants, and contact investigations around an index
TB patient, and 2) BCG vaccination. Additionally MPHSs
offer (primary) preventive treatment to child contacts with
TB infection identified in contact investigation. Until
2002, BCG-vaccinated TB contacts, including children,
were screened only with chest X-ray and were not eligible
for LTBI screening [14]. In 2002, LTBI screening using
TST was introduced for all children, including those
BCG-vaccinated. From 2007, LTBI screening using inter-
feron gamma release assays (IGRA) in TST-positive con-
tacts (two step approach) was recommended [15].
In the Netherlands BCG vaccination is targeted to
new-born children with a parent born in a country with
estimated TB incidence >50 per 100,000 population. Im-
migrant children younger than 12 years of age, with no
evidence of BCG-vaccination at entry screening for TB
and a negative tuberculin skin test (TST) are offered
BCG-vaccination. Non-BCG-vaccinated children with a
positive TST are offered preventive treatment for latent
tuberculosis infection (LTBI).
The effectiveness of TB control efforts among children
in the Netherlands has not been evaluated before. This
study aims to describe trends and characteristics of TB
and LTBI among children and to evaluate TB control ef-
forts through the identification of risk factors for delayed
case finding and exploring opportunities where preven-
tion can be further improved.
Methods
Data from all notified TB and LTBI cases in 1993–2012
were retrieved from the Netherlands TB Register (NTR).
All clinical and bacteriologically confirmed TB cases are
mandatory notified to the MPHSs. Since 1993 the MPHSs
report all mandatory notified TB cases in a central registry.
Additionally, they voluntarily report all new LTBI cases di-
agnosed and eligible for preventive treatment. The web-
based notification process for both TB and LTBI cases, has
an average timeline of 6–12 months and consists of four
parts: 1) notification, 2) demographic and clinical cha-
racteristics, including laboratory confirmation and DNA
fingerprint results, 3) patient management and (prevent-
ive) treatment outcome and 4) results of contact investiga-
tion (from 2006 onwards). Registered data include method
of case finding and ethnic origin.
We analyzed the trend in incidence for all notified TB
and LTBI cases in the period 1993–2012 comparing TB
incidence among children younger than 15 years of age
with TB incidence among adults, stratified by ethnic
group defined as foreign-born, native Dutch (born in the
Netherlands and both parents born in the Netherlands)
and second generation immigrant (born in the Netherlands
and at least one parent foreign-born). Population data for
the calculation of incidence rates were obtained from the
Office of National Statistics, Statistics Netherlands (CBS).
CBS population data on ethnic groups are available from
1996 onwards. Linear trend analysis was done in Excel
(Microsoft Office 2007).
We described characteristics by age group and method
of case finding for childhood TB cases notified in the
period 2005–2012. This period was selected to describe
the more recent cases and avoid registration bias, as the
content of the data collection questionnaire was changed
in 2005. We conducted logistic regression analysis in
SPSS 19.0 (Chicago, IL, USA) to identify person and dis-
ease characteristics associated with passive case finding
as a proxy for delayed case finding. Variables yielding
a p-value <0.2 in univariate analysis were included in
multivariate analysis, and the most parsimonious model
was selected by backward elimination guided by the
change in log likelihood and coefficients of successive
models.
Opportunities in prevention were categorized according
to three levels of opportunities for prevention: primary)
vaccination and source case investigation, secondary) iden-
tification and preventive treatment of children with LTBI
and tertiary) early case finding and treatment completion.
As outcome indicators we chose coverage of the existing
preventive interventions (BCG vaccination and contact in-
vestigation) among children identified with TB and LTBI,
percentage of children with TB identified through entry
screening among the target group, and unsuccessful com-
pletion rates of both preventive and curative treatment.
Children with TB who potentially could have been identi-
fied with LTBI through screening on entry and offered
preventive treatment, were also included as an indicator of
opportunity for prevention, although at the time of the
registration of the cases, the national guideline only recom-
mended this screening in non-BCG vaccinated children.
Results
Trend analysis childhood TB incidence 1993–2012
The absolute number of children with TB decreased from
106 in 1993 to 50 in 2012, with a corresponding incidence
of 3.6 and 1.9 per 100,000 population (p < 0.001). From
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1993 until 2000 there was no clear change in the annual
incidence. Since 2001 the average annual decline in child-
hood TB cases was 2.6%. The percentage of child TB cases
among all cases declined from 6.7% in 1993 to 5.2% in
2012 (p = 0.001). The incidence rate declined markedly
from 1996–2012 among native Dutch children (1.4 to 0.5
per 100,000 (p < 0.001)), native Dutch adults (5.8 to 1.4
per 100,000 (p < 0.001) and foreign-born adults (71.4 to
39.6 per 100,000 (p = 0.003) (Figures 1 and 2). No signifi-
cant trends were observed among foreign-born children
(34.9 to 37.8 per 100,000, p = 0.81), among second ge-
neration children (7.7 to 6.1 per 100,000, p = 0.38), and
among second generation adults (4.7 to 4.0 per 100,000,
p = 0.53).
Characteristics of children with TB 2005–2012
In summary, 403 children with TB disease were regis-
tered, 5% of all notified cases in 2005–2012 (Table 1).
Of all children with TB, 56 (14%) were younger than
2 years and 98 (24%) were 2–4 years old. Child TB pa-
tients were more often born in the Netherlands than
adult patients, but 60% of the children were second ge-
neration immigrants. Foreign-born children with TB
were mostly born in Somalia (46%) and other sub-Sahara
African countries (24%). The most common forms of TB
among children were primary TB infection (35%) and pul-
monary TB (38%). Two children aged 10–14 years were
diagnosed with multi-drug resistant TB. No relapse TB
cases among children were observed.
Overall, 32% of childhood TB diagnoses were confirmed
with a positive culture; 68% of passively detected cases
and 12% of actively detected cases. In passively detected
patients, culture was performed in 117/145 (81%) cases
and 98/117 (84%) were culture positive. In contrast, cul-
ture was performed in 74/258 (29%) actively detected
cases and of these cases 31/74 (41%) were culture positive.
After adjustment for ethnicity and type of TB, the associ-
ation between passive case finding and culture perform-
ance was still present (OR adj. 2.6, 95% CI 1.2-5.3).
Treatment outcome
Fifteen percent of children with TB were admitted to a
hospital compared with 33% of adult TB cases (Table 1).
Treatment was more often administered under DOT in
children (51%) than in adults (28%). In total 94% of the
children completed TB treatment with success, compared
with 86% of adults. Few child TB cases (2%) interrupted
the treatment: five children younger than 5 years of age
and three children older than 5 years. Three children died
due to TB and one from other causes. Serious forms of
TB were associated with a high risk of mortality: two of
the seven children with miliary TB died from TB.
Trends in diagnosis of LTBI
From 1993 to 2002 the annual number of children diag-
nosed and reported with LTBI increased from 100 to
257, an average increase of 17% per year. After 2002, the
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Figure 2 Trend in tuberculosis incidence in children by ethnic
origin in the Netherlands, 1996–2012.
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decrease was most marked among native Dutch children
and second generation immigrant children: the number
of LTBI diagnoses decreased with 85% and 63% respect-
ively (Figure 3). Among foreign-born children, the num-
ber of LTBI diagnoses remained more or less stable.
Characteristics of children with LTBI
In the period 2005–2012 1120 children with LTBI were
notified, 8% of all notified persons with LTBI (Table 2).
Overall 21% of these children were foreign-born and
46% were second generation migrants. The majority
Table 1 Characteristics of TB cases in the Netherlands 2005-2012
< 5 years 5-14 years Total 0–14 years >14 years Total (all ages)
n % of age
group
n % of age
group
n % of age
group
n % n % of age
group
Total TB cases (% of total notified) 154 (2%) 249 (3%) 403 (5%) 7954 (95%) 8357 (100%)
Male 82 53% 112 45% 194 48% 4574 58% 4768 57%
Dutch born, including both parents 33 21% 69 28% 102 25% 1914 24% 2016 24%
Dutch born, 2d generation immigrant 91 59% 63 25% 154 38% 381 5% 535 6%
Foreign-born 30 19% 116 47% 146 36% 5,645 71% 5791 69%
WHO incidence 2008 country of origin
<50 4 13% 8 7% 12 8% 870 15% 882 16%
50-199 7 23% 24 21% 31 21% 2673 47% 2704 48%
>200 19 63% 84 70% 68% 2116 37% 2185 39%
Site of TB disease
- Primary TB infection 72 47% 69 28% 141 35% 117 1% 258 3%
- Pulmonary TB 51 33% 86 35% 137 34% 4189 53% 4326 52%
- TB pleuritis 1 1% 7 3% 8 2% 560 7% 568 7%
- Other TB of respiratory tract, including
intrathoracic lymph nodes
15 10% 35 14% 50 12% 896 11% 946 11%
- TB of peripheral lymph nodes 7 5% 32 13% 39 10% 1260 16% 1299 16%
- miliary TB 3 2% 7 3% 10 2% 203 3% 213 3%
- TB meningitis 3 2% 4 2% 7 2% 177 2% 184 2%
- Bone and joint TB 0 0% 5 2% 5 1% 341 4% 346 4%
- TB of other organ tracts 2 1% 10 4% 12 3% 732 9% 744 9%
Culture positive 36 23% 93 37% 129 32% 5,867 74% 4611 55%
History of TB contact 105 68% 132 53% 237 59% 606 8% 843 10%
Hiv-co-infection 1 1% 2 1% 1% 326 4% 329 4%
Diagnosis by MPHS 104 68% 140 56% 244 61% 1509 19% 1753 21%
Active case finding
- Contact investigation 101 66% 128 51% 229 57% 390 5% 619 7%
- Screening immigrants 11 7% 18 7% 29 7% 856 11% 885 11%
Hospital admission >1 week 23 15% 41 16% 64 16% 2652 33% 2716 32%
Daily observed treatment 88 57% 116 47% 204 51% 2114 27% 2318 28%
Adverse events* 4 3% 12 5% 16 4% 1022 13% 1038 12%
Treatment Outcome 135 218 353 7046 7399
- Success 124 92% 207 95% 331 94% 6070 86% 6401 87%
- Defaulted 5 4% 3 1% 8 2% 255 4% 263 4%
- Death caused by TB 2 1% 1 0% 3 1% 135 2% 138 2%
- Death caused by other cause 1 1% 0 0% 1 0.3% 271 4% 272 4%
- Transfer out/unknown 3 2% 7 3% 10 3% 315 4% 325 4%
Definition of abbreviations: NL Netherlands, CI contact investigation, MPHS Municipal Public Health Service, HIV human immunodeficiency virus, TB tuberculosis,
BCG Bacillus Calmette-Guérin.
*Adverse events- defined as events demanding an interruption or change of the treatment regimen.
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(83%) of children with LTBI was diagnosed in the context
of contact investigations. This proportion was lower among
foreign-born children (55%) who relatively more often
were detected through entry screening (18%) and before
BCG vaccination (27%) (data not shown). The acceptance
rate of preventive treatment was higher in children (94%)
compared to adults (72%) (p < 0.001). Children starting
preventive treatment also completed the treatment signifi-
cantly more often than adults (90% versus 81%, p < 0.001).
Opportunities for prevention
An overview of the opportunities of TB control is given
in Table 3. In 37% of all TB cases there was a ‘missed’
opportunity for prevention.
In terms of opportunities for primary prevention through
BCG vaccination, 212 (53%) children with TB were eligible
for BCG vaccination, of whom 83 (39%) were reported
as not BCG-vaccinated. Fifty-one (61%) of these children
were younger than 5 years of age, of whom 46 were born
in the Netherlands. Foreign-born child TB patients were
more often BCG-vaccinated (54%) compared with second-
generation migrant child TB patients (35%). Seventeen out
of 139 (12%) children younger than 5 years and in 15/335
(4%) children aged 5–11 years at entry in the Netherlands
were not BCG vaccinated. Four children with TB men-
ingitis and five children with miliary TB belonged to the
target group for BCG-vaccination, seven of these chil-
dren were not vaccinated. Of 474 children eligible for
BCG vaccination and diagnosed with LTBI, 163 (34%)
were reported as not vaccinated with BCG.
Data on source and contact investigation (SCI) were
available for 347 (86%) children. In 184 (53%) cases a SCI
was not performed or unknown SCI was not undertaken
in 26 (17%) passively detected cases with no known his-
tory of TB contact. When no SCI was performed the
majority of the children (149 (81%)) had been detected
through SCI or screening themselves.
In terms of opportunities for secondary prevention, 27
children with TB within the first 2.5 years after migra-
tion to the Netherlands, could probably have been iden-
tified with TB infection at entry screening. Furthermore,
16 child TB contacts were not identified with TB or TB
infection by contact investigation. Of children identified
with LTBI, 71 (6%) did not start preventive treatment
and 85 (8%) did not complete treatment.
In terms of opportunities for tertiary prevention, the
majority of children with TB were found through active
case finding (73% in children <5 years and 59% in children
5–14 years), mostly through contact investigation. In total
15 TB cases (31% of the target group) were missed by
screening at entry in the Netherlands (Table 3). Overall
3% of the children with a known treatment outcome did
not complete the TB treatment successfully.
The proportion of cases detected through active case
finding was lowest among foreign-born children with
length of stay 7–30 months (40%) and >2.5 years (41%)
in the Netherlands (Table 4). These selected groups
showed a significantly higher risk to be detected through
passive case finding compared to native Dutch children,
after adjustment for type of TB (OR adj. 3.9, 95% CI
1.4-10.7 and 2.7, 95% CI 1.0-6.8 respectively).
Discussion
Our study shows that in the Netherlands the number of
children with TB and children with LTBI declined with
more than 50% over the last decade. The trend in child-
hood TB incidence mirrors the overall decline in TB
incidence. Nearly two thirds of children with TB were
detected through active case finding in contrast with
16% of adults. However, among foreign-born and second
generation immigrant children no significant decline in
TB incidence was observed and foreign born children
were more likely to be detected through the develop-
ment of symptomatic TB disease.
The quality of the diagnosis of TB in children seems
to be high compared to other low prevalence countries
[16-21], with culture confirmation rates of TB in children
detected passively up to 68%, only slightly lower than in
adults (74%). Treatment results exceed the international
standards of 85% successful treatment completion, both
for curative and preventive treatment. For every child di-
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Figure 3 Latent tuberculosis infection in children < 15 years by
ethnic origin in the Netherlands 1993–2012.
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identified and started on preventive treatment. Assuming
a life time risk for progression to TB disease of 5-10% [22]
and an effectiveness of preventive treatment of 70% [23]
35–65 child TB cases are likely to have been prevented in
the period 2005–2012. However, for 37% of child TB cases
there was at least one ‘missed opportunity for prevention’
identified, among which absence of BCG vaccination in
children from target groups was the most frequent.
Our study gives a representative picture of both notified
child TB and LTBI cases in the Netherlands. The data rep-
resent both symptomatic cases detected in the curative
sector as cases detected and managed ambulatory in the
Table 2 Characteristics of persons notified with LTBI 2005–2012
< 5 years 5-14 years Total 0–14 years >14 years Total (all ages)
n % of age
group
n % of age
group
n % of age
group
n % of age
group
n % of age
group
Total new LTBI cases
(% of total notified)
298 (2%) 822 (6%) 1120 (8%) 12121 (92%) 13241 (100%)
Ethnic origin
- Native Dutch 43 14% 261 32% 304 27% 6820 56% 7124 54%
- Foreign-born 50 17% 190 23% 240 21% 2,899 24% 3139 24%
- 2d generation immigrant 186 62% 328 40% 514 46% 607 5% 1121 8%
- Unknown* 19 6% 43 5% 62 6% 1795 15% 1857 14%
Detected through contact
investigation
227 76% 708 86% 935 83% 6957 57% 7892 60%
Preventive treatment started 283 95% 766 93% 1049 94% 8669 72% 9718 73%
- Of whom completed 249 (88%) 690 (90%) 939 (90%) 7009 (81%) 7948 (82%)
(% of preventive treatment)
-Defaulter 25 (9%) 47 (6%) 72 (7%) 1157 (13%) 1229 (13%)
-Transfer out/unknown 9 (3%) 29 (4%) 38 (4%) 497 (6%) 535 (6%)
*Country of birth is unknown in 106 persons among whom 3 children country and of origin of the parents is unknown in 1505 persons among whom
53 children. Definition of abbreviations: NL Netherlands, BCG Bacillus Calmette-Guérin.
Table 3 Indicators of (missed) opportunities in childhood tuberculosis control 2005-2012








Children with LTBI belonging to target groups of BCG vaccination
without BCG vaccination
163 474 34%
Children with TB belonging to target groups of BCG vaccination
without BCG vaccination
83 212 39%
Children with TB meningitis or miliary TB belonging to target
groups of BCG vaccination without evidence of BCG vaccination
7 9 78%
Children with passively detected TB and no known source case





Foreign-born children with TB 7–30 months after entry in the
Netherlands and detected passively through the development
of symptoms
27 45 60%
Children with TB reported with a history of contact with infectious
TB patient but not detected through contact investigation
16 237 7%
Children with LTBI not started on preventive treatment 71 1120 6%
Children not completing preventive treatment 85 1024 8%
Tertiary prevention:
early case finding and
adequate treatment
of TB
Foreign-born children with TB < 6 months after entry in the
Netherlands and detected passively through the development
of symptoms
15 48 31%
Children with TB with an unfavorable outcome of TB treatment 14 375 4%
Overall* Children with TB and at least 1 missed opportunity for prevention 150 403 37%
*Children may have more than one ‘missed’ opportunity for TB prevention. Definition of abbreviations: NL Netherlands, TB tuberculosis, LTBI latent tuberculosis
infection, BCG Bacillus Calmette-Guérin.
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public health sector by the MPHSs. Sub analysis shows
that foreign-born children with TB were less likely to be
found through active case finding and that these children
more often had advanced culture-positive TB disease.
A limitation of our study is that the data are retrieved
from the routine TB surveillance registry and are not
collected systematically with a strict research design. The
Dutch surveillance system is generally regarded as sound
and representative of TB incidence [24], but specific data
e.g. on BCG vaccination status and laboratory results may
be less complete. We chose presence of BCG scar or proof
of vaccination as a proxy for BCG status, but in passively
detected TB cases BCG status is not relevant for the clin-
ical management and therefore more likely to be missing.
Thus BCG vaccination coverage among the child TB cases
may be underestimated.
We observed an overall culture-confirmation rate of 32%
in TB diagnosis in children. Similar low rates have also
been reported recently in other low-endemic countries
[2,17,18,25,26]. However in our study, the culture confirm-
ation rate among children with advanced, passively de-
tected TB was high and comparable to the rate in adults.
This is comparable or higher than rates reported in other
studies ranging from 40%-64% among cases from whom
material for culture was obtained [2,4,19]. Moreover,
nearly two thirds of child TB cases were detected through
active case finding, mainly through contact investigation.
In this group the culture-confirmation rate was low be-
cause culture was not performed in 65% of the cases, but
confirmation was also low in cases where culture was
attempted. This reflects the difficulty to obtain culture
confirmation in early TB disease in children as well as the
Dutch consensus that the combination of obvious expos-
ure, immunologic evidence of TB infection and radio-
logical signs on the chest X-ray suggestive for primary
TB infection allows for accurate diagnosis in this low-
incidence setting. The drug susceptibility pattern of the
putative source case guides the choice of treatment. Not
Table 4 Characteristics of childhood TB cases in the Netherlands 2005–2012 according to method of case finding, and
characteristics associated with risk to be detected with passive case finding
Method of case detection Unadjusted
OR (95% CI)
Adjusted#
OR (95% CI)Active case finding Passive case finding
Number (row%) Number (row%)
Total 258 (64%) 145 (36%)
Age group 0-1 years 39 (70%) 17 (30%) 0.40 (0.21-0.77)
2-4 years 73 (74%) 25 (26%) 0.31 (0.18-0.55)
5-9 years 79 (72%) 30 (28%) 0.35 (0.20-0.60)
10-14 years 67 (48%) 73 (52%) 1.0
Ethnic origin foreign-born subtotal foreign-born 71 (56%) 76 (44%) 4.6 (2.4-8.8)
in NL since 0-6 months 31 (65%) 17 (35%) 2.3 (1.0-5.2) 1.4 (0.54-3.7)
7-30 months 18 (40%) 27 (60%) 6.3 (2.8-14.3) 3.9 (1.4-10.7)
> 2.5. years 22 (41%) 32 (59%) 6.1 (2.8-13.4) 2.7 (1.0-6.8)
Dutch born both parents Dutch born 63 (81%) 15 (19%) 1.0
2d generation immigrant 124 (70%) 54 (30%) 1.8 (0.96-3.5) 1.4 (0.63-2.9)
BCG BCG-vaccinated 67 (54%) 57 (46%) 1.8 (1.2-2.9)
No BCG vaccination or unknown 191 (68%) 88 (32%) 1.0
Type of TB PTB + PETB subtotal PTB + PETB 162 (66%) 88 (34%)
ZN positive 6 (18%) 27 (82%) 17.8 (6.6-48.2) 7.4 (2.4-23.0)
ZN negative, culture positive 21 (38%) 34 (62%) 6.2 (3.0-12.7) 3.0 (1.2-7.2)
culture negative or unknown 135 (86%) 22 (14%) 0.67 (0.36-1.3) 0.60 (0.31-1.2)
ETB subtotal ETB 96 (61%) 62 (39%)
culture positive 5 (11%) 83 (89%) 30.9 (10.9-87.1) 11.6 (3.6-37.4)
culture negative or unknown 91 (80%) 23 (20%) 1.0 1.0
Culture not done or unknown 184 (87%) 28 (13%) 10.4 (6.3-17.0) 2.6 (1.2-5.3)
culture performed 74 (39%) 117 (61%) 1.0 1.0
Definition of abbreviations: CI confidence interval, OR odds ratio, BCG Bacille Calmette-Guérin, PTB pulmonary tuberculosis, ETB extrapulmonary tuberculosis, PETB
combined pulmonary and extrapulmonary tuberculosis, NL Netherlands, ZN Ziehl Neelsen microscopy of sputum. Categories in italics are subtotals and not used in
the regression analysis.
#Covariates used in the multivariate regression analysis: Age group, ethnic origin, BCG, type of TB and culture.
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endeavoring to obtain bacteriological confirmation through
invasive methods in these circumstances is considered an
effective, child-friendly and cost-saving approach.
TB incidence rates did decline among Dutch children
but did not decline proportionally among child immigrant
populations. In 2012, second generation migrant children
had a 12 times higher risk to be diagnosed with TB than
native Dutch children and foreign-born children had an
80 times higher risk. This reflects the high risk of trans-
mission in the home countries and continuous risk of
transmission among immigrant population groups after
arrival in the Netherlands. Our study shows several op-
portunities for prevention of TB among these children.
Varying results have been found in other high income
countries with a low prevalence of TB [19,25,27]. Univer-
sal coverage of BCG vaccination in target groups would
have most impact on the occurrence of TB, as nearly 40%
of children with TB belonging to the target groups of BCG
vaccination were not vaccinated, of whom 61% younger
than 5 years of age. Assuming a 50% risk reduction follow-
ing BCG-vaccination [12], at least 40 cases, 10% of the
total case load in children, could have been prevented.
Furthermore, recently evidence emerged that BCG may
protect against TB infection, as well as the development of
TB disease after infection [28,29]. BCG coverage is esti-
mated to be below 60% in the Netherlands [30]. Based
on a cost effectiveness analysis [31] the National Health
Council recommends to continue targeted BCG vaccin-
ation among new-born children of parents originating
from TB endemic areas with a WHO estimated incidence
of > 50 per 100.000 population. To enhance the coverage
the National Health Council recently recommended to in-
clude BCG vaccination in the national expanded child-
hood immunization program [30]. Our data support this
recommendation.
Other interventions with potential impact on the occur-
rence of TB specifically among immigrant children, are
improved contact investigation practices and screening
and preventive treatment for LTBI on entry screening.
Currently, only non-BCG vaccinated children younger
than 12 years of age are tested for LTBI on entry in the
Netherlands. However, more than half of the foreign-born
children cases developed TB within 2.5 years in the
Netherlands. It is likely that a considerable proportion of
these children could have been detected with LTBI on
entry in the Netherlands. Therefore the feasibility and
cost-effectiveness of preventive treatment in immigrant
children needs to be studied.
Conclusion
TB case finding and TB treatment among children in
the Netherlands is comparatively well managed, as evi-
denced by the fact that in the majority of cases a rapid
diagnosis is made at an early stage through contact
investigation and risk group screening. Furthermore, treat-
ment success rates are high and no relapse cases were doc-
umented. It is likely that considerable TB morbidity and
mortality among children in the Netherlands has been pre-
vented through active case finding and preventive treat-
ment of infected cases. However, excess mortality and
morbidity may be further prevented through improved im-
plementation of existing preventive measures such as tar-
geted BCG vaccination and diagnosis and treatment of
LTBI among foreign born children, and exploring feasi-
bility and (cost) effectiveness of screening and preventive
treatment of LTBI in children from TB high endemic
countries.
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